4th Quarter - Termination
DB3, LLC (FKA THE DASCHLE GROUP) for VALISURE
Client
Income
$20,000
Expenses
—
Terminated
Nov 1, 2024
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to pharmaceutical safety and efficacy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE CARELLI | — |
Defense DEF
Issues related to pharmaceutical safety and efficacy, generally; FY25 DoD appropriations, issues related to pharmaceutical safety and efficacy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE CARELLI | — |
Veterans VET
Issues related to pharmaceutical safety and efficacy, generally; FY25 Milcon-VA appropriations, issues related to pharmaceutical safety and efficacy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE CARELLI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.